pegylated interferon-alfa 2a

DRUG2 trials

Sponsors

PV-Nord, Vir Biotechnology, Inc.

Conditions

Chronic Hepatitis BPolycythemia Vera

Phase 2

Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera

CompletedNCT00241241

PV-NordPolycythemia Vera

Start: 2004-09-30End: 2008-01-31Target: 40Updated: 2015-10-21

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

CompletedNCT04412863

Vir Biotechnology, Inc.Chronic Hepatitis B

Start: 2020-07-03End: 2024-03-25Updated: 2024-09-19

Related Papers

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera.

2008-07-23424 citations